DalCor Pharmaceuticals IPO

dalcorpharma.comHealthcare / BioTech & Pharma

DalCor Pharmaceuticals, founded in 2015, is a biopharmaceutical company seeking to find better ways to treat cardiovascular disease through a combination of genetic exploration and clinical therapies. DalCor Pharmaceuticals’ proprietary development program, dalcetrapib, combines that approach to reduce the impact of myocardial infarction (MI) in patients. DalCor Pharmaceuticals is headquartered in Montreal, Canada.

Buy or sell DalCor Pharmaceuticals stock Learn more about DalCor Pharmaceuticals stock

Learn more about DalCor Pharmaceuticals

Is DalCor Pharmaceuticals a publicly traded company?

DalCor Pharmaceuticals is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Will DalCor Pharmaceuticals go IPO?

DalCor Pharmaceuticals has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is DalCor Pharmaceuticals's IPO price?

The IPO price for DalCor Pharmaceuticals will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.

Can you invest in DalCor Pharmaceuticals pre-IPO?

DalCor Pharmaceuticals is privately held company and is not publicly traded, therefor investing in DalCor Pharmaceuticals pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

What is the value of my DalCor Pharmaceuticals shares?

To determine the value of your DalCor Pharmaceuticals shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your DalCor Pharmaceuticals shares. You can also learn more about how to sell your private shares before getting started.

Can you sell DalCor Pharmaceuticals before it goes public?

Yes, you can seek to sell shares in DalCor Pharmaceuticals while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

When was DalCor Pharmaceuticals founded?

DalCor Pharmaceuticals was founded in 2015.

Who are DalCor Pharmaceuticals's major investors?

Andes

CTI Life Sciences Fund

Sanderling Ventures

T&B Pharma

Investissement Quebec

Fonds de solidarité FTQ

Caisse de dépôt et placement du Québec

Fonds de Developpement Économique

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.